Biosynthesis of flavin cofactors in man: Implications in health and disease

Current Pharmaceutical Design

Volumn 19, Issue 14, 2013, Pages 2649-2675

  Barile, Maria ^a,b   Giancaspero, Teresa Anna ^a   Brizio, Carmen ^a   Panebianco, Concetta ^a   Indiveri, Cesare ^c   Galluccio, Michele ^c   Vergani, Lodovica ^d   Eberini, Ivano ^e   Gianazza, Elisabetta ^e  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Amyotrophic lateral sclerosis; FAD synthase; FLAD1; Flavin cofactors; FLX1; Novel antibiotic drugs; Riboflavin homeostasis; Riboflavin responsive pathologies

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; GLUTATHIONE REDUCTASE; ISOENZYME; QUERCETIN DERIVATIVE; RIBOFLAVIN;

ABSORPTION; AUTOFLUORESCENCE; BIOSYNTHESIS; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CHEMICAL STRUCTURE; CLINICAL FEATURE; COMPLEX I DEFICIENCY; COMPLEX II DEFICIENCY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME PURIFICATION; EUKARYOTE; FRIEDREICH ATAXIA; GENE; HOMEOSTASIS; HUMAN; INTESTINE; INTESTINE ABSORPTION; KIDNEY; LIVER; METABOLIC DISORDER; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITION; NUTRITIONAL STATUS; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RIBOFLAVIN DEFICIENCY; TRANSPORT KINETICS;

AMINO ACID SEQUENCE; ANIMALS; FLAVIN MONONUCLEOTIDE; FLAVIN-ADENINE DINUCLEOTIDE; HOMEOSTASIS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RIBOFLAVIN; RIBOFLAVIN DEFICIENCY; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY;

EID: 84877812406     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319140014     Document Type: Review

References (256)

1. McCormick DB. Two interconnected B vitamins: riboflavin and pyridoxine. Physiol Rev 1989; 69: 1170-98.
2. Massey V. The chemical and biological versatility of riboflavin. Biochem Soc Trans 2000; 28: 283-96.
3. Massey V. Introduction: flavoprotein structure and mechanism. Faseb J 1995; 9: 473-5.
4. Merrill AH, Jr., Lambeth JD, Edmondson DE, McCormick DB. Formation and mode of action of flavoproteins. Annu Rev Nutr 1981; 1: 281-317.
5. Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem Biol Interact 2006 (a); 163: 94-112.
6. Macheroux P, Kappes B, Ealick SE. Flavogenomics-a genomic and structural view of flavin-dependent proteins. FEBS J 2011; 278: 2625-34.
7. Joosten V, van Berkel WJ. Flavoenzymes. Curr Opin Chem Biol 2007; 11: 195-202.
8. De Colibus L, Mattevi A. New frontiers in structural flavoenzymology. Curr Opin Struct Biol 2006; 16: 722-8.
9. Mansoorabadi SO, Thibodeaux CJ, Liu HW. The diverse roles of flavin coenzymes--nature's most versatile thespians. J Org Chem 2007; 72: 6329-42.
10. Gibson QH, Massey V, Atherton NM. The nature of compounds present in mixtures of oxidized and reduced flavin mononucleotides. Biochem J 1962; 85: 369-83.
11. Murataliev MB. Application of electron spin resonance (ESR) for detection and characterization of flavoprotein semiquinones. Methods Mol Biol 1999; 131: 97-110.
12. Torchetti EM, Bonomi F, Galluccio M, et al. Human FAD synthase (isoform 2): a component of the machinery that delivers FAD to apo-flavoproteins. FEBS J 2011; 278: 4434-49.
13. Barile M, Brizio C, De Virgilio C, Delfine S, Quagliariello E, Passarella S. Flavin adenine dinucleotide and flavin mononucleotide metabolism in rat liver-the occurrence of FAD pyrophosphatase and FMN phosphohydrolase in isolated mitochondria. Eur J Biochem 1997; 249: 777-85.
14. King TE, Howard RL, Wilson DF, Li JC. The partition of flavins in the heart muscle preparation and heart mitochondria. J Biol Chem 1962; 237: 2941-6.
15. Ghisla S, Massey V, Lhoste JM, Mayhew SG. Fluorescence and optical characteristics of reduced flavines and flavoproteins. Biochemistry 1974; 13: 589-97.
16. Brizio C, Brandsch R, Douka M, Wait R, Barile M. The purified recombinant precursor of rat mitochondrial dimethylglycine dehydrogenase binds FAD via an autocatalytic reaction. Int J Biol Macromol 2008; 42: 455-62.
17. Singer TP, Edmondson DE. Flavoproteins (overview). Methods Enzymol 1978; 53: 397-418.
18. Caldinelli L, Iametti S, Barbiroli A, et al. Unfolding intermediate in the peroxisomal flavoprotein D-amino acid oxidase. J Biol Chem 2004; 279: 28426-34.
19. Garland PB, Chance B, Ernster L, Lee CP, Wong D. Flavoproteins of mitochondrial fatty acid oxidation. Proc Natl Acad Sci U S A 1967; 58: 1696-702.
20. Scholz R, Thurman RG, Williamson JR, Chance B, Bucher T. Flavin and pyridine nucleotide oxidation-reduction changes in perfused rat liver. I. Anoxia and subcellular localization of fluorescent flavoproteins. J Biol Chem 1969; 244: 2317-24.
21. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. II. Difference spectra. J Biol Chem 1955; 217: 395-407.
22. Chance B, Legallais V, Schoener B. Metabolically linked changes in fluorescence emission spectra of cortex of rat brain, kidney and adrenal gland. Nature 1962; 195: 1073-5.
23. Kunz WS, Kunz W. Contribution of different enzymes to flavoprotein fluorescence of isolated rat liver mitochondria. Biochim Biophys Acta 1985; 841: 237-46.
24. Heikal AA. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. Biomark Med 2010; 4: 241-63.
25. Reinert KC, Gao W, Chen G, Ebner TJ. Flavoprotein autofluorescence imaging in the cerebellar cortex in vivo. J Neurosci Res 2007; 85: 3221-32.
26. Tohmi M, Takahashi K, Kubota Y, Hishida R, Shibuki K. Transcranial flavoprotein fluorescence imaging of mouse cortical activity and plasticity. J Neurochem 2009; 109 Suppl 1: 3-9.
27. Bacher A, Eberhardt S, Fischer M, Kis K, Richter G. Biosynthesis of vitamin b2 (riboflavin). Annu Rev Nutr 2000; 20: 153-67.
28. Hustad S, McKinley MC, McNulty H, et al. Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin Chem 2002; 48: 1571-7.
29. Innis WS, McCormick DB, Merrill AH, Jr. Variations in riboflavin binding by human plasma: identification of immunoglobulins as the major proteins responsible. Biochem Med 1985; 34: 151-65.
30. Zempleni J, Galloway JR, McCormick DB. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr 1996; 63: 54-66.
31. Chastain JL, McCormick DB. Flavin catabolites: identification and quantitation in human urine. Am J Clin Nutr 1987; 46: 830-4.
32. Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr 2003; 77: 1352-60.
33. Nakano E, Mushtaq S, Heath PR, et al. Riboflavin depletion impairs cell proliferation in adult human duodenum: identification of potential effectors. Dig Dis Sci 2011; 56: 1007-19.
34. Powers HJ, Hill MH, Mushtaq S, Dainty JR, Majsak-Newman G, Williams EA. Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM). Am J Clin Nutr 2011; 93: 1274-84.
35. Lee SS, McCormick DB. Effect of riboflavin status on hepatic activities of flavin-metabolizing enzymes in rats. J Nutr 1983; 113: 2274-9.
36. Ross NS, Hansen TP. Riboflavin deficiency is associated with selective preservation of critical flavoenzyme-dependent metabolic pathways. Biofactors 1992; 3: 185-90.
37. Olpin SE, Bates CJ. Lipid metabolism in riboflavin-deficient rats. 1. Effect of dietary lipids on riboflavin status and fatty acid profiles. Br J Nutr 1982; 47: 577-96.
38. Hoppel CL, Tandler B. Riboflavin deficiency. Prog Clin Biol Res 1990; 321: 233-48.
39. Gianazza E, Vergani L, Wait R, et al. Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient. Electrophoresis 2006; 27: 1182-98.
40. Giancaspero TA, Wait R, Boles E, Barile M. Succinate dehydrogenase flavoprotein subunit expression in Saccharomyces cerevisiae-involvement of the mitochondrial FAD transporter, Flx1p. FEBS J 2008; 275: 1103-17.
41. Powers HJ, Corfe BM, Nakano E. Riboflavin in development and cell fate. Subcell Biochem 2012; 56: 229-45.
42. Werner R, Manthey KC, Griffin JB, Zempleni J. HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium. J Nutr Biochem 2005; 16: 617-24.
43. Said HM, Ma TY. Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells. Am J Physiol 1994; 266: G15-21.
44. Manthey KC, Rodriguez-Melendez R, Hoi JT, Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem 2006; 17: 250-6.
45. Hustad S, Ueland PM, Schneede J. Quantification of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma by capillary electrophoresis and laser-induced fluorescence detection. Clin Chem 1999; 45: 862-8.
46. Petteys BJ, Frank EL. Rapid determination of vitamin B (riboflavin) in plasma by HPLC. Clin Chim Acta 2011; 412: 38-43.
47. Weber F, Glatzle D, Wiss O. The assessment of riboflavin status. Proc Nutr Soc 1973; 32: 237-41.
48. Mushtaq S, Su H, Hill MH, Powers HJ. Erythrocyte pyridoxamine phosphate oxidase activity: a potential biomarker of riboflavin status? Am J Clin Nutr 2009; 90: 1151-9.
49. Moat SJ, Ashfield-Watt PA, Powers HJ, Newcombe RG, McDowell IF. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem 2003; 49: 295-302.
50. Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of B vitamins on the onecarbon transfer pathways. Chem Biol Interact 2006 (b); 163: 113-32.
51. Kiuchi K, Nishikimi M, Yagi K. L-gulonolactone oxidase activity and vitamin C status in riboflavin-deficient rats. Biochim Biophys Acta 1980; 630: 330-7.
52. Wollers S, Layer G, Garcia-Serres R, et al. Iron-sulfur (Fe-S) cluster assembly: the SufBCD complex is a new type of Fe-S scaffold with a flavin redox cofactor. J Biol Chem 2010; 285: 23331-41.
53. Foraker AB, Khantwal CM, Swaan PW. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv Drug Deliv Rev 2003; 55: 1467-83.
54. Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochem J 2011; 437: 357-72.
55. Said HM, Hollander D, Mohammadkhani R. Uptake of riboflavin by intestinal basolateral membrane vesicles: a specialized carriermediated process. Biochim Biophys Acta 1993; 1148: 263-8.
56. Yanagawa N, Jo OD, Said HM. Riboflavin transport by rabbit renal brush border membrane vesicles. Biochim Biophys Acta 1997; 1330: 172-8.
57. Kumar CK, Yanagawa N, Ortiz A, Said HM. Mechanism and regulation of riboflavin uptake by human renal proximal tubule epithelial cell line HK-2. Am J Physiol 1998; 274: F104-10.
58. Yanagawa N, Shih RN, Jo OD, Said HM. Riboflavin transport by isolated perfused rabbit renal proximal tubules. Am J Physiol Cell Physiol 2000; 279: C1782-6.
59. Aw TY, Jones DP, McCormick DB. Uptake of riboflavin by isolated rat liver cells. J Nutr 1983; 113: 1249-54.
60. Said HM, McCloud E, Yanagawa N. Riboflavin uptake by rat liver basolateral membrane vesicles. Biochim Biophys Acta 1995; 1236: 244-8.
61. Said HM, Ortiz A, Ma TY, McCloud E. Riboflavin uptake by the human-derived liver cells Hep G2: mechanism and regulation. J Cell Physiol 1998; 176: 588-94.
62. Hegazy E, Schwenk M. Riboflavin uptake by isolated enterocytes of guinea pigs. J Nutr 1983; 113: 1702-7.
63. Daniel H, Wille U, Rehner G. In vitro kinetics of the intestinal transport of riboflavin in rats. J Nutr 1983; 113: 636-43.
64. Middleton HM, 3rd. Uptake of riboflavin by rat intestinal mucosa in vitro. J Nutr 1990; 120: 588-93.
65. Daniel H, Rehner GI. Sodium-dependent transport of riboflavin in brush border membrane vesicles of rat small intestine is an electrogenic process. J Nutr 1992; 122: 1454-61.
66. Casirola D, Gastaldi G, Ferrari G, Kasai S, Rindi G. Riboflavin uptake by rat small intestinal brush border membrane vesicles: a dual mechanism involving specific membrane binding. J Membr Biol 1993; 135: 217-23.
67. Gastaldi G, Ferrari G, Verri A, Casirola D, Orsenigo MN, Laforenza U. Riboflavin phosphorylation is the crucial event in riboflavin transport by isolated rat enterocytes. J Nutr 2000; 130: 2556-61.
68. Gastaldi G, Laforenza U, Casirola D, Ferrari G, Tosco M, Rindi G. Energy depletion differently affects membrane transport and intracellular metabolism of riboflavin taken up by isolated rat enterocytes. J Nutr 1999; 129: 406-9.
69. Yuasa H, Hirobe M, Tomei S, Watanabe J. Carrier-mediated transport of riboflavin in the rat colon. Biopharm Drug Dispos 2000; 21: 77-82.
70. Tomei S, Yuasa H, Inoue K, Watanabe J. Transport functions of riboflavin carriers in the rat small intestine and colon: site difference and effects of tricyclic-type drugs. Drug Deliv 2001; 8: 119-24.
71. Said HM, Mohammadkhani R, McCloud E. Mechanism of transport of riboflavin in rabbit intestinal brush border membrane vesicles. Proc Soc Exp Biol Med 1993; 202: 428-34.
72. Said HM, Arianas P. Transport of riboflavin in human intestinal brush border membrane vesicles. Gastroenterology 1991; 100: 82-8.
73. Said HM, Ma TY, Grant K. Regulation of riboflavin intestinal uptake by protein kinase A: studies with Caco-2 cells. Am J Physiol 1994; 267: G955-9.
74. Said HM, Ortiz A, Moyer MP, Yanagawa N. Riboflavin uptake by human-derived colonic epithelial NCM460 cells. Am J Physiol Cell Physiol 2000; 278: C270-6.
75. Huang SN, Swaan PW. Involvement of a receptor-mediated component in cellular translocation of riboflavin. J Pharmacol Exp Ther 2000; 294: 117-25.
76. Huang SN, Swaan PW. Riboflavin uptake in human trophoblastderived BeWo cell monolayers: cellular translocation and regulatory mechanisms. J Pharmacol Exp Ther 2001; 298: 264-71.
77. Spector R, Boose B. Active transport of riboflavin by the isolated choroid plexus in vitro. J Biol Chem 1979; 254: 10286-9.
78. Hakvoort A, Haselbach M, Galla HJ. Active transport properties of porcine choroid plexus cells in culture. Brain Res 1998; 795: 247-56.
79. Said HM, Wang S, Ma TY. Mechanism of riboflavin uptake by cultured human retinal pigment epithelial ARPE-19 cells: possible regulation by an intracellular Ca2+-calmodulin-mediated pathway. J Physiol 2005; 566: 369-77.
80. Kansara V, Pal D, Jain R, Mitra AK. Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation. J Ocul Pharmacol Ther 2005; 21: 275-87.
81. Reihl P, Stolz J. The monocarboxylate transporter homolog Mch5p catalyzes riboflavin (vitamin B2) uptake in Saccharomyces cerevisiae. J Biol Chem 2005; 280: 39809-17.
82. Perl M, Kearney EB, Singer TP. Transport of riboflavin into yeast cells. J Biol Chem 1976; 251: 3221-8.
83. Sibirnyi AA, Shavlovskii GM, Ksheminskaia GP, Orlovskaia AG. [Active transport of riboflavin in the yeast Pichia guilliermondii. Detection and some properties of the cryptic riboflavin permease]. Biokhimiia 1977; 42: 1841-51.
84. Moriyama Y. Riboflavin transporter is finally identified. J Biochem 2011; 150: 341-3.
85. Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS. Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucleic Acids Res 2002; 30: 3141-51.
86. Vogl C, Grill S, Schilling O, Stulke J, Mack M, Stolz J. Characterization of riboflavin (vitamin B2) transport proteins from Bacillus subtilis and Corynebacterium glutamicum. J Bacteriol 2007; 189: 7367-75.
87. Burgess CM, Slotboom DJ, Geertsma ER, Duurkens RH, Poolman B, van Sinderen D. The riboflavin transporter RibU in Lactococcus lactis: molecular characterization of gene expression and the transport mechanism. J Bacteriol 2006; 188: 2752-60.
88. Hemberger S, Pedrolli DB, Stolz J, Vogl C, Lehmann M, Mack M. RibM from Streptomyces davawensis is a riboflavin/roseoflavin transporter and may be useful for the optimization of riboflavin production strains. BMC Biotechnol 2011; 11: 119.
89. Yonezawa A, Masuda S, Katsura T, Inui K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am J Physiol Cell Physiol 2008; 295: C632-41.
90. Yamamoto S, Inoue K, Ohta KY, et al. Identification and functional characterization of rat riboflavin transporter 2. J Biochem 2009; 145: 437-43.
91. Fujimura M, Yamamoto S, Murata T, et al. Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption. J Nutr 2011; 140: 1722-7.
92. Yao Y, Yonezawa A, Yoshimatsu H, Masuda S, Katsura T, Inui K. Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J Nutr 2010; 140: 1220-6.
93. van Herwaarden AE, Wagenaar E, Merino G, et al. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol 2007; 27: 1247-53.
94. Subramanian VS, Subramanya SB, Rapp L, Marchant JS, Ma TY, Said HM. Differential expression of human riboflavin transporters-1,-2, and-3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake. Biochim Biophys Acta 2011; 1808: 3016-21.
95. Vlaming ML, Lagas JS, Schinkel AH. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 2009; 61: 14-25.
96. Yatsyshyn V, Fedorovych D, Sibirny A. The microbial synthesis of flavin nucleotides: A review. Applied Biochemistry and Microbiology 2009; 45: 115-124.
97. Frago S, Martinez-Julvez M, Serrano A, Medina M. Structural analysis of FAD synthetase from Corynebacterium ammoniagenes. BMC Microbiol 2008; 8: 160.
98. Herguedas B, Martinez-Julvez M, Frago S, Medina M, Hermoso JA. Oligomeric state in the crystal structure of modular FAD synthetase provides insights into its sequential catalysis in prokaryotes. J Mol Biol 2010; 400: 218-30.
99. Mashhadi Z, Xu H, Grochowski LL, White RH. Archaeal RibL: a new FAD synthetase that is air sensitive. Biochemistry 2010; 49: 8748-55.
100. Mashhadi Z, Zhang H, Xu H, White RH. Identification and characterization of an archaeon-specific riboflavin kinase. J Bacteriol 2008; 190: 2615-8.
101. McCormick DB. A trail of research on cofactors: an odyssey with friends. J Nutr 2000; 130: 323S-330S.
102. Ochoa S, Rossiter RJ. Flavin-adenine-dinucleotide in rat tissues. Biochem J 1939; 33: 2008-16.
103. Klein JR, Kohn HI. The synthesis of Flavin-Adenine dinucleotide from riboflavin by human blood cells in vitro and in vivo. J Biol Chem 1940; 136: 177-189.
104. Schrecker AW, Kornberg A. Reversible enzymatic synthesis of flavin-adenine dinucleotide. J Biol Chem 1950; 182: 795-803.
105. Deluca C, Kaplan NO. Flavin adenine dinucleotide synthesis in animal tissues. Biochim Biophys Acta 1958; 30: 6-11.
106. Oka M, McCormick DB. Complete purification and general characterization of FAD synthetase from rat liver. J Biol Chem 1987; 262: 7418-22.
107. McCormick DB, Oka M, Bowers-Komro DM, Yamada Y, Hartman HA. Purification and properties of FAD synthetase from liver. Methods Enzymol 1997; 280: 407-13.
108. Barile M, Passarella S, Bertoldi A, Quagliariello E. Flavin adenine dinucleotide synthesis in isolated rat liver mitochondria caused by imported flavin mononucleotide. Arch Biochem Biophys 1993; 305: 442-7.
109. Wu M, Repetto B, Glerum DM, Tzagoloff A. Cloning and characterization of FAD1, the structural gene for flavin adenine dinucleotide synthetase of Saccharomyces cerevisiae. Mol Cell Biol 1995; 15: 264-71.
110. Bafunno V, Giancaspero TA, Brizio C, et al. Riboflavin uptake and FAD synthesis in Saccharomyces cerevisiae mitochondria: involvement of the Flx1p carrier in FAD export. J Biol Chem 2004; 279: 95-102.
111. Barile M, Brizio C, Valenti D, De Virgilio C, Passarella S. The riboflavin/FAD cycle in rat liver mitochondria. Eur J Biochem 2000; 267: 4888-900.
112. Brizio C, Galluccio M, Wait R, et al. Over-expression in Escherichia coli and characterization of two recombinant isoforms of human FAD synthetase. Biochem Biophys Res Commun 2006; 344: 1008-16.
113. Galluccio M, Brizio C, Torchetti EM, et al. Over-expression in Escherichia coli, purification and characterization of isoform 2 of human FAD synthetase. Protein Expr Purif 2007; 52: 175-81.
114. Huerta C, Borek D, Machius M, Grishin NV, Zhang H. Structure and mechanism of a eukaryotic FMN adenylyltransferase. J Mol Biol 2009; 389: 388-400.
115. Leulliot N, Blondeau K, Keller J, Ulryck N, Quevillon-Cheruel S, van Tilbeurgh H. Crystal structure of yeast FAD synthetase (Fad1) in complex with FAD. J Mol Biol 2010; 398: 641-6.
116. Torchetti EM, Brizio C, Colella M, et al. Mitochondrial localization of human FAD synthetase isoform 1. Mitochondrion 2010; 10: 263-73.
117. Pedrolli DB, Nakanishi S, Barile M, et al. The antibiotics roseoflavin and 8-demethyl-8-amino-riboflavin from Streptomyces davawensis are metabolized by human flavokinase and human FAD synthetase. Biochem Pharmacol 2011; 82: 1853-9.
118. Vergani L, Barile M, Angelini C, et al. Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies. Brain 1999; 122 (Pt 12): 2401-11.
119. Yruela I, Arilla-Luna S, Medina M, Contreras-Moreira B. Evolutionary divergence of chloroplast FAD synthetase proteins. BMC Evol Biol 2010; 10: 311.
120. Maruta T, Yoshimoto T, Ito D, et al. An Arabidopsis FAD Pyrophosphohydrolase, AtNUDX23, is Involved in the Flavin Homeostasis. Plant Cell Physiol 2012; 53: 1106-13.
121. Kearney EB, Englard S. Enzymatic synthesis of flavin mononucleotide. Arch Biochem Biophys 1951; 32: 222-3.
122. Kashchenko VE, Shavlovskii GM. [Purification and properties of the riboflavin kinase of the yeast Pichia guilliermondii]. Biokhimiia 1976; 41: 376-83.
123. Merrill AH, Jr., McCormick DB. Affinity chromatographic purification and properties of flavokinase (ATP:riboflavin 5'-phosphotransferase) from rat liver. J Biol Chem 1980; 255: 1335-8.
124. Gomes B, McCormick DB. Purification and general characterization of FAD synthetase from rat liver. Proc Soc Exp Biol Med 1983; 172: 250-4.
125. Yamada Y, Merrill AH, Jr., McCormick DB. Probable reaction mechanisms of flavokinase and FAD synthetase from rat liver. Arch Biochem Biophys 1990; 278: 125-30.
126. Lee SS, McCormick DB. Thyroid hormone regulation of flavocoenzyme biosynthesis. Arch Biochem Biophys 1985; 237: 197-201.
127. Giancaspero TA, Locato V, de Pinto MC, De Gara L, Barile M. The occurrence of riboflavin kinase and FAD synthetase ensures FAD synthesis in tobacco mitochondria and maintenance of cellular redox status. FEBS J 2009; 276: 219-31.
128. Liuzzi VC, Giancaspero TA, Gianazza E, Banfi C, Barile M, De Giorgi C. Silencing of FAD synthase gene in Caenorhabditis elegans upsets protein homeostasis and impacts on complex behavioral patterns. Biochim Biophys Acta 2012; 1820: 521-31.
129. Hino S, Sakamoto A, Nagaoka K, et al. FAD-dependent lysinespecific demethylase-1 regulates cellular energy expenditure. Nat Commun 2012; 3: 758.
130. Tzagoloff A, Jang J, Glerum DM, Wu M. FLX1 codes for a carrier protein involved in maintaining a proper balance of flavin nucleotides in yeast mitochondria. J Biol Chem 1996; 271: 7392-7.
131. Spaan AN, Ijlst L, van Roermund CW, Wijburg FA, Wanders RJ, Waterham HR. Identification of the human mitochondrial FAD transporter and its potential role in multiple acyl-CoA dehydrogenase deficiency. Mol Genet Metab 2005; 86: 441-7.
132. Titus SA, Moran RG. Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria. J Biol Chem 2000; 275: 36811-7.
133. Lawrence SA, Hackett JC, Moran RG. Tetrahydrofolate recognition by the mitochondrial folate transporter. J Biol Chem 2011; 286: 31480-9.
134. Santos MA, Jimenez A, Revuelta JL. Molecular characterization of FMN1, the structural gene for the monofunctional flavokinase of Saccharomyces cerevisiae. J Biol Chem 2000; 275: 28618-24.
135. Bauer S, Kemter K, Bacher A, Huber R, Fischer M, Steinbacher S. Crystal structure of Schizosaccharomyces pombe riboflavin kinase reveals a novel ATP and riboflavin-binding fold. J Mol Biol 2003; 326: 1463-73.
136. Karthikeyan S, Zhou Q, Mseeh F, Grishin NV, Osterman AL, Zhang H. Crystal structure of human riboflavin kinase reveals a beta barrel fold and a novel active site arch. Structure 2003 (a); 11: 265-73.
137. Karthikeyan S, Zhou Q, Osterman AL, Zhang H. Ligand bindinginduced conformational changes in riboflavin kinase: structural basis for the ordered mechanism. Biochemistry 2003 (b); 42: 12532-8.
138. Wang W, Kim R, Yokota H, Kim SH. Crystal structure of flavin binding to FAD synthetase of Thermotoga maritima. Proteins 2005; 58: 246-8.
139. Iatsishin V, Fedorovich DV, Sibirnyi AA. [The microbial synthesis of flavin nucleotides: a review]. Prikl Biokhim Mikrobiol 2009; 45: 133-42.
140. Pallotta ML, Brizio C, Fratianni A, De Virgilio C, Barile M, Passarella S. Saccharomyces cerevisiae mitochondria can synthesise FMN and FAD from externally added riboflavin and export them to the extramitochondrial phase. FEBS Lett 1998; 428: 245-9.
141. Kuper J, Llamas A, Hecht HJ, Mendel RR, Schwarz G. Structure of the molybdopterin-bound Cnx1G domain links molybdenum and copper metabolism. Nature 2004; 430: 803-6.
142. Llamas A, Mendel RR, Schwarz G. Synthesis of adenylated molybdopterin: an essential step for molybdenum insertion. J Biol Chem 2004; 279: 55241-6.
143. Galluccio M, Giancaspero TA, Miccolis A, Panebianco C, Indiveri C, Barile M. Relevance of Cys residues of human FAD synthase (isoform 2) in the protein function/structure as assessed by homology modeling and site directed mutagenesis Proceedings of 17th International Symposium on Flavins and Flavoproteins, IUMBM S3/2011, 24-29 July 2011, Berkeley, CA, USA 2011; (in press).
144. Gerdes SY, Scholle MD, D'Souza M, Bernal A, Baev MV, Farrell M, Kurnasov OV, Daugherty MD, Mseeh F, Polanuyer BM, Campbell JW, et al. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J Bacteriol 2002; 184: 4555-72.
145. Giancaspero TA, Torchetti EM, Latronico T, Brizio C, Colella M, Liuzzi GM, Barile M. Unravelling the relevance of fad synthetase in human physiopathology. a biotechnological approach. European Journal of Clinical Investigation 2010; 40: 65-65.
146. Gerbino A, Maiellaro I, Carmone C, et al. Glucose increases extracellular [Ca2+] in rat insulinoma (INS-1E) pseudoislets as measured with Ca2+-sensitive microelectrodes. Cell Calcium 2012; 51: 393-401.
147. Lin J, Diamanduros A, Chowdhury SA, Scelsa S, Latov N, Sadiq SA. Specific electron transport chain abnormalities in amyotrophic lateral sclerosis. J Neurol 2009; 256: 774-82.
148. Wong MM, Cox LK, Chrivia JC. The chromatin remodeling protein, SRCAP, is critical for deposition of the histone variant H2A. Z at promoters. J Biol Chem 2007; 282: 26132-9.
149. Giancaspero TA, Torchetti EM, Iametti S, Bonomi F, Barile M. Kinetic properties of human FAD synthetase isoform 2 and probable reaction mechanism. FEBS J 2011; 278: Erratum page 1.
150. Ye H, Rouault TA. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 2010; 49: 4945-56.
151. Bonomi F, Iametti S, Morleo A, Ta D, Vickery LE. Studies on the mechanism of catalysis of iron-sulfur cluster transfer from IscU[2Fe2S] by HscA/HscB chaperones. Biochemistry 2008; 47: 12795-801.
152. Padovani D, Banerjee R. A rotary mechanism for coenzyme B(12) synthesis by adenosyltransferase. Biochemistry 2009; 48: 5350-7.
153. Brizio C, Giancaspero TA, Brandsch R, Barile M. Mitochondriaassisted flavinylation of recombinant rat dimethylglycine dehydrogenase. Proceedings of 17th International Symposium on Flavins and Flavoproteins, IUMBM S3/2011, 24-29 July 2011, Berkeley, CA, USA 2011; (in press).
154. Fraaije MW, Mattevi A. Flavoenzymes: diverse catalysts with recurrent features. Trends Biochem Sci 2000; 25: 126-32.
155. Heuts DP, Scrutton NS, McIntire WS, Fraaije MW. What's in a covalent bond? On the role and formation of covalently bound flavin cofactors. FEBS J 2009; 276: 3405-27.
156. Leferink NG, Heuts DP, Fraaije MW, van Berkel WJ. The growing VAO flavoprotein family. Arch Biochem Biophys 2008; 474: 292-301.
157. Edmondson DE, Newton-Vinson P. The covalent FAD of monoamine oxidase: structural and functional role and mechanism of the flavinylation reaction. Antioxid Redox Signal 2001; 3: 789-806.
158. Valenti D, Atlante A, Barile M, Passarella S. Mitochondria as agents of disease and as drug targets. In "Mitochondrial Pharmacology and Toxicology" (António J. M. MorenPaulo J. Oliveira and Carlos M. Palmeira eds.) 2006: 113-145.
159. Saijo T, Tanaka K. Isoalloxazine ring of FAD is required for the formation of the core in the Hsp60-assisted folding of medium chain acyl-CoA dehydrogenase subunit into the assembly competent conformation in mitochondria. J Biol Chem 1995; 270: 1899-907.
160. Henriques BJ, Rodrigues JV, Olsen RK, Bross P, Gomes CM. Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: a molecular rationale for the effects of riboflavin supplementation. J Biol Chem 2009; 284: 4222-9.
161. Gregersen N, Andresen BS, Pedersen CB, Olsen RK, Corydon TJ, Bross P. Mitochondrial fatty acid oxidation defects--remaining challenges. J Inherit Metab Dis 2008; 31: 643-57.
162. Olsen RK, Olpin SE, Andresen BS, et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 2007; 130: 2045-54.
163. Watmough NJ, Frerman FE. The electron transfer flavoprotein: ubiquinone oxidoreductases. Biochim Biophys Acta 2010; 1797: 1910-6.
164. Cornelius N, Frerman FE, Corydon TJ, et al. Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency. Hum Mol Genet 2012; 21: 3435-48.
165. Ghezzi D, Sevrioukova I, Invernizzi F, et al. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am J Hum Genet 2010; 86: 639-49.
166. Lucas TG, Henriques BJ, Rodrigues JV, Bross P, Gregersen N, Gomes CM. Cofactors and metabolites as potential stabilizers of mitochondrial acyl-CoA dehydrogenases. Biochim Biophys Acta 2011; 1812: 1658-63.
167. Mewies M, McIntire WS, Scrutton NS. Covalent attachment of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to enzymes: the current state of affairs. Protein Sci 1998; 7: 7-20.
168. Mihalik SJ, McGuinness M, Watkins PA. Purification and characterization of peroxisomal L-pipecolic acid oxidase from monkey liver. J Biol Chem 1991; 266: 4822-30.
169. Walker WH, Singer TP. Identification of the covalently bound flavin of succinate dehydrogenase as 8-alpha-(histidyl) flavin adenine dinucleotide. J Biol Chem 1970; 245: 4224-5.
170. Kenney WC, Edmondson DE, Singer TP. Identification of the covalently bound flavin of L-gulono-gamma-lactone oxidase. Biochem Biophys Res Commun 1976; 71: 1194-200.
171. Kiuchi K, Nishikimi M, Yagi K. Purification and characterization of L-gulonolactone oxidase from chicken kidney microsomes. Biochemistry 1982; 21: 5076-82.
172. Nagy J, Salach JI. Identity of the active site flavin-peptide fragments from the human "A"-form and the bovine "B"-form of monoamine oxidase. Arch Biochem Biophys 1981; 208: 388-94.
173. Kearney EB, Salach JI, Walker WH, et al. The covalently-bound flavin of hepatic monoamine oxidase. 1. Isolation and sequence of a flavin peptide and evidence for binding at the 8alpha position. Eur J Biochem 1971; 24: 321-7.
174. Walker WH, Kearney EB, Seng RL, Singer TP. The covalentlybound flavin of hepatic monoamine oxidase. 2. Identification and properties of cysteinyl riboflavin. Eur J Biochem 1971; 24: 328-31.
175. Robinson KM, Lemire BD. Covalent attachment of FAD to the yeast succinate dehydrogenase flavoprotein requires import into mitochondria, presequence removal, and folding. J Biol Chem 1996; 271: 4055-60.
176. Cook RJ, Misono KS, Wagner C. Identification of the covalently bound flavin of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver mitochondria. J Biol Chem 1984; 259: 12475-80.
177. Otto A, Stoltz M, Sailer HP, Brandsch R. Biogenesis of the covalently flavinylated mitochondrial enzyme dimethylglycine dehydrogenase. J Biol Chem 1996; 271: 9823-9.
178. Brizio C, Otto A, Brandsch R, Passarella S, Barile M. A protein factor of rat liver mitochondrial matrix involved in flavinylation of dimethylglycine dehydrogenase. Eur J Biochem 2000; 267: 4346-54.
179. Rao VV, Tsai MJ, Pan X, Chang YF. L-pipecolic acid oxidation in rat: subcellular localization and developmental study. Biochim Biophys Acta 1993; 1164: 29-35.
180. Kearney EB, Singer TP. On the prosthetic group of succinic dehydrogenase. Biochim Biophys Acta 1955; 17: 596-7.
181. Singer TP, Kearney EB, Massey V. Observations on the flavin moiety of succinic dehydrogenase. Arch Biochem Biophys 1956; 60: 255-7.
182. Decker K, Brandsch R. Determining covalent flavinylation. Methods Enzymol 1997; 280: 413-23.
183. Robinson KM, Lemire BD. Flavinylation of succinate: ubiquinone oxidoreductase from Saccharomyces cerevisiae. Methods Enzymol 1995; 260: 34-51.
184. Moolenaar SH, Poggi-Bach J, Engelke UF, et al. Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin Chem 1999; 45: 459-64.
185. McAndrew RP, Vockley J, Kim JJ. Molecular basis of dimethylglycine dehydrogenase deficiency associated with pathogenic variant H109R. J Inherit Metab Dis 2008; 31: 761-8.
186. Brizio C, Barile M, Brandsch R. Flavinylation of the precursor of mitochondrial dimethylglycine dehydrogenase by intact and solubilised mitochondria. FEBS Lett 2002; 522: 141-6.
187. Cook RJ, Misono KS, Wagner C. The amino acid sequences of the flavin-peptides of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver mitochondria. J Biol Chem 1985; 260: 12998-3002.
188. Hao HX, Khalimonchuk O, Schraders M, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009; 325: 1139-42.
189. McNeil MB, Clulow JS, Wilf NM, Salmond GP, Fineran PC. SdhE is a conserved protein required for the flavinylation of succinate dehydrogenase in bacteria. J Biol Chem 2012.
190. Nagao M, Tanaka K. FAD-dependent regulation of transcription, translation, post-translational processing, and post-processing stability of various mitochondrial acyl-CoA dehydrogenases and of electron transfer flavoprotein and the site of holoenzyme formation. J Biol Chem 1992; 267: 17925-32.
191. Zahedi RP, Sickmann A, Boehm AM, et al. Proteomic analysis of the yeast mitochondrial outer membrane reveals accumulation of a subclass of preproteins. Mol Biol Cell 2006; 17: 1436-50.
192. Patel HH, Insel PA. Lipid rafts and caveolae and their role in compartmentation of redox signaling. Antioxid Redox Signal 2009; 11: 1357-72.
193. Simmen T, Lynes EM, Gesson K, Thomas G. Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta 2010; 1798: 1465-73.
194. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
195. Yazdanpanah B, Wiegmann K, Tchikov V, et al. Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature 2009; 460: 1159-63.
196. Park KJ, Lee CH, Kim A, Jeong KJ, Kim CH, Kim YS. Death receptors 4 and 5 activate Nox1 NADPH oxidase through riboflavin kinase to induce reactive oxygen species-mediated apoptotic cell death. J Biol Chem 2012; 287: 3313-25.
197. Tu BP, Weissman JS. Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 2004; 164: 341-6.
198. Tu BP, Weissman JS. The FAD-and O(2)-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol Cell 2002; 10: 983-94.
199. Protchenko O, Rodriguez-Suarez R, Androphy R, Bussey H, Philpott CC. A screen for genes of heme uptake identifies the FLC family required for import of FAD into the endoplasmic reticulum. J Biol Chem 2006; 281: 21445-57.
200. Varsanyi M, Szarka A, Papp E, et al. FAD transport and FADdependent protein thiol oxidation in rat liver microsomes. J Biol Chem 2004; 279: 3370-4.
201. Agrimi G, Russo A, Scarcia P, Palmieri F. The Human Gene Slc25a17 Encodes a Peroxisomal Transporter of Coenzyme a, Fad and Nad+. Biochem J 2012.
202. Sevrioukova IF. Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid Redox Signal 2011; 14: 2545-79.
203. Horvath R. Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ(10). J Inherit Metab Dis 2011.
204. Gregersen N, Wintzensen H, Christensen SK, Christensen MF, Brandt NJ, Rasmussen K. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res 1982; 16: 861-8.
205. Gregersen N. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies. Scand J Clin Lab Invest Suppl 1985; 174: 1-60.
206. Antozzi C, Garavaglia B, Mora M, et al. Late-onset riboflavinresponsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency. Neurology 1994; 44: 2153-8.
207. Russell AP, Schrauwen P, Somm E, et al. Decreased fatty acid beta-oxidation in riboflavin-responsive, multiple acylcoenzyme A dehydrogenase-deficient patients is associated with an increase in uncoupling protein-3. J Clin Endocrinol Metab 2003; 88: 5921-6.
208. Triggs WJ, Roe CR, Rhead WJ, Hanson SK, Lin SN, Willmore LJ. Neuropsychiatric manifestations of defect in mitochondrial beta oxidation response to riboflavin. J Neurol Neurosurg Psychiatry 1992; 55: 209-11.
209. Morris AA, Turnbull DM. Fatty acid oxidation defects in muscle. Curr Opin Neurol 1998; 11: 485-90.
210. Er TK, Liang WC, Chang JG, Jong YJ. High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Clin Chim Acta 2011; 411: 690-9.
211. Izumi R, Suzuki N, Nagata M, et al. A case of late onset riboflavinresponsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure. Intern Med 2011; 50: 2663-8.
212. Wang ZQ, Chen XJ, Murong SX, Wang N, Wu ZY. Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A. J Mol Med (Berl) 2011; 89: 569-76.
213. Cotelli MS, Vielmi V, Rimoldi M, et al. Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect. Neurol Sci 2011.
214. Ho G, Yonezawa A, Masuda S, et al. Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria Type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172B. Hum Mutat 2011; 32: E1976-84.
215. Rhead W, Roettger V, Marshall T, Amendt B. Multiple acylcoenzyme A dehydrogenation disorder responsive to riboflavin: substrate oxidation, flavin metabolism, and flavoenzyme activities in fibroblasts. Pediatr Res 1993; 33: 129-35.
216. Yilmaz K. Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 2009; 13: 57-60.
217. Kmoch S, Zeman J, Hrebicek M, Ryba L, Kristensen MJ, Gregersen N. Riboflavin-responsive epilepsy in a patient with SER209 variant form of short-chain acyl-CoA dehydrogenase. J Inherit Metab Dis 1995; 18: 227-9.
218. Bosch AM, Abeling NG, Ijlst L, et al. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis 2010; 34: 159-64.
219. Sathasivam S. Brown-Vialetto-Van Laere syndrome. Orphanet J Rare Dis 2008; 3: 9.
220. Green P, Wiseman M, Crow YJ, et al. Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet 2010; 86: 485-9.
221. Dipti S, Childs AM, Livingston JH, et al. Brown-Vialetto-Van Laere syndrome; variability in age at onset and disease progression highlighting the phenotypic overlap with Fazio-Londe disease. Brain Dev 2005; 27: 443-6.
222. Anand G, Hasan N, Jayapal S, et al. Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome. Dev Med Child Neurol 2012; 54: 187-9.
223. Haack TB, Makowski C, Yao Y, et al. Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome. J Inherit Metab Dis 2012.
224. Koy A, Pillekamp F, Hoehn T, et al. Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene. Pediatr Neurol 2012; 46: 407-9.
225. Bernsen PL, Gabreels FJ, Ruitenbeek W, Hamburger HL. Treatment of complex I deficiency with riboflavin. J Neurol Sci 1993; 118: 181-7.
226. Gerards M, van den Bosch BJ, Danhauser K, et al. Riboflavinresponsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. Brain 2011; 134: 210-9.
227. Scholte HR, Busch HF, Bakker HD, Bogaard JM, Luyt-Houwen IE, Kuyt LP. Riboflavin-responsive complex I deficiency. Biochim Biophys Acta 1995; 1271: 75-83.
228. Haack TB, Danhauser K, Haberberger B, et al. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 2010; 42: 1131-4.
229. Pinard JM, Marsac C, Barkaoui E, et al. [Leigh syndrome and leukodystrophy due to partial succinate dehydrogenase deficiency: regression with riboflavin]. Arch Pediatr 1999; 6: 421-6.
230. Bugiani M, Lamantea E, Invernizzi F, et al. Effects of riboflavin in children with complex II deficiency. Brain Dev 2006; 28: 576-81.
231. Gonzalez-Cabo P, Ros S, Palau F. Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency. PLoS One 2010; 5: e8872.
232. Cimino JA, Jhangiani S, Schwartz E, Cooperman JM. Riboflavin metabolism in the hypothyroid human adult. Proc Soc Exp Biol Med 1987; 184: 151-3.
233. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011; 7: 616-30.
234. Wang J, Farr GW, Hall DH, et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet 2009; 5: e1000350.
235. van Ham TJ, Breitling R, Swertz MA, Nollen EA. Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Mol Med 2009; 1: 360-70.
236. Liao QL, Chen XD, Zhao L, Ding YQ. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS]. Nan Fang Yi Ke Da Xue Xue Bao 2008; 28: 154-8.
237. Siassi F, Ghadirian P. Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev 2005; 29: 464-9.
238. Wang LD, Zhou FY, Li XM, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010; 42: 759-63.
239. Burnichon N, Briere JJ, Libe R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010; 19: 3011-20.
240. Hensen EF, Bayley JP. Recent advances in the genetics of SDHrelated paraganglioma and pheochromocytoma. Fam Cancer 2011; 10: 355-63.
241. Bardella C, Pollard PJ, Tomlinson I. SDH mutations in cancer. Biochim Biophys Acta 2011; 1807: 1432-43.
242. Hamajima S, Ono S, Hirano H, Obara K. Induction of the FAD synthetase system in rat liver by phenobarbital administration. Int J Vitam Nutr Res 1979; 49: 59-63.
243. Lee ER, Blount KF, Breaker RR. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol 2009; 6: 187-94.
244. Ott E, Stolz J, Lehmann M, Mack M. The RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis. RNA Biol 2009; 6: 276-80.
245. Mansjo M, Johansson J. The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection. RNA Biol 2011; 8: 674-80.
246. Muller IB, Hyde JE, Wrenger C. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets. Trends Parasitol 2010; 26: 35-43.
247. Akompong T, Ghori N, Haldar K. In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 2000; 44: 88-96.
248. Hirano M, Matsuki T, Tanishima K, et al. Congenital methaemoglobinaemia due to NADH methaemoglobin reductase deficiency: successful treatment with oral riboflavin. Br J Haematol 1981; 47: 353-9.
249. Dutta P, Pinto J, Rivlin R. Antimalarial effects of riboflavin deficiency. Lancet 1985; 2: 1040-3.
250. Kaikai P, Thurnham DI. The influence of riboflavin deficiency on Plasmodium berghei infection in rats. Trans R Soc Trop Med Hyg 1983; 77: 680-6.
251. Das BS, Thurnham DI, Patnaik JK, Das DB, Satpathy R, Bose TK. Increased plasma lipid peroxidation in riboflavin-deficient, malaria-infected children. Am J Clin Nutr 1990; 51: 859-63.
252. de Souza Queiroz KC, Zambuzzi WF, Santos de Souza AC, et al. A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumours. Cancer Lett 2007; 258: 126-34.
253. Breitkopf SB, Oppermann FS, Keri G, Grammel M, Daub H. Proteomics analysis of cellular imatinib targets and their candidate downstream effectors. J Proteome Res 2010; 9: 6033-43.
254. Hirano G, Izumi H, Yasuniwa Y, et al. Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin. Int J Oncol 2011; 38: 893-902.
255. Keating A, Pineda R, 2nd, Colby K. Corneal cross linking for keratoconus. Semin Ophthalmol 2010; 25: 249-55.
256. Sauer A, Letscher-Bru V, Speeg-Schatz C, et al. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci 2010; 51: 3950-3.